Comparative Pharmacology
Head-to-head clinical analysis: RESECTISOL versus RESECTISOL IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: RESECTISOL versus RESECTISOL IN PLASTIC CONTAINER.
RESECTISOL vs RESECTISOL IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetic acid acts as a sclerosing agent by inducing protein denaturation and inflammatory response, leading to fibrosis and obliteration of vascular channels. It also has antimicrobial properties by disrupting cell membranes.
RESECTISOL (mannitol) is an osmotic diuretic that increases osmotic pressure of glomerular filtrate, thereby inhibiting tubular reabsorption of water and electrolytes, leading to increased urine output. It also reduces intracranial pressure and cerebral edema by creating an osmotic gradient that draws water from brain tissue into plasma.
Adults: 1–2 mL/kg intravenously once daily.
36 mg/mL acetic acid solution instilled into the renal pelvis via nephrostomy catheter; single dose of 60-240 mL depending on stone burden, retained for 10-15 minutes, then aspirated. May be repeated weekly up to 3 doses.
None Documented
None Documented
30–45 min; prolonged to 2–4 hours in hepatic impairment or with concurrent halothane.
Terminal half-life: 1.5–2 hours (predominantly determined by redistribution; prolonged in hepatic impairment).
Primarily renal excretion of unchanged drug (≥90%); <5% fecal.
Renal: ~50-60% as unchanged drug and metabolites; biliary/fecal: ~35-40% (mainly metabolites).
Category C
Category C
Irrigating Solution
Irrigating Solution